ADI-PEG treatment protects against colitis in 2 distinct phenotypic animal models, BALB/c wildtypes as well as IL-10 deficient mice, presumably due to the attenuation of inflammatory markers such as SAA, suppression of macrophage infiltration, and iNOS expression in colonic tissues. This evidence concerns the gene IL10 and colitis.